One (1) Brand Name or Equal Mabtech IRIS 2 Immunoassay Reader

Amendment P00001 - The purpose of this amendment is to provide a response to questions recieved pertaining to the RFQ. Please see attachment entitled "Response_RFQ Questions" All other RFQ infromation and facts remain the same and unchanged.

This Request for Quote is being issued by National Institutes of Health (NIH), National Cancer Institute (NCI), Office of Acquisitions (OA), on behalf of the, Center for Cancer Research (CCR), Center for Immuno-Oncology (CIO), which currently has a need for one (1) Brand Name or Equal Mabtech IRIS 2 Immunoassay Reader.

This is a Combined Synopsis/Solicitation for commercial items, prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, as supplemented with additional information included in this notice, and shall be processed in accordance with FAR Part 13 - Simplified Acquisition Procedures. This announcement constitutes the only solicitation that will be provided in relation to the stated need contained herein.

This solicitation is issued as a Request for Quote (RFQ) and includes applicable provisions and clauses in effect through FAR Federal Acquisition Circular (FAC) 2024-03 (02/23/2024). The requirement’s North American Industry Classification System (NAICS) code is 334516 (Analytical Laboratory Instrument Manufacturing) with a size standard of 1,000 employees. One firm fixed priced award is anticipated to be made as a result of this solicitation.

Please see attached documents for additional Information and submittal Instructions